Genomics Market
Genomics Market Size, Share & Trends Analysis Report by Deliverable (Products and Service), by Technology (Sequencing, PCR, Nucleic Acid Extraction & Purification, Microarray, CRISPR and Other), by Application (Drug Discovery & Development, Diagnostics, Agriculture & Animal Research, Precision Medicine and Other), and by End-User (Hospitals & Clinics, Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Clinical, Research Organizations (CROs) and Other), Forecast Period (2026-2035)
Industry Overview
Genomics market was valued at $29.5 billion in 2025 and is projected to reach $84.4 billion by 2035, growing at a CAGR of 11.2% during the forecast period (2026-2035). The genomics market is experiencing steady expansion, driven by the increasing use of genomic technologies in medical research and clinical diagnostics. Advances in sequencing technologies and molecular analysis tools have significantly improved the speed and accuracy of genetic data generation. Growing investment in drug discovery and personalized medicine is further encouraging the adoption of genomics-based approaches across pharmaceutical and biotechnology companies. In addition, rising demand for early disease detection and genetic testing is supporting the integration of genomics in healthcare systems. Research institutions and clinical laboratories are also expanding their genomic capabilities to support complex biological studies. Continuous technological innovation and broader application of genomics across healthcare and agricultural research are expected to sustain market growth in the coming years.
Market Dynamics
Growing Integration of Genomics in Clinical Diagnostics
The use of genomics in clinical diagnostics is expanding as healthcare systems increasingly adopt genetic testing for disease identification and risk assessment. Genomic technologies enable detailed analysis of genetic mutations and biomarkers associated with various medical conditions, including cancer and inherited disorders. Hospitals and diagnostic laboratories are incorporating genomic testing to support more accurate and early diagnosis. This integration is also helping clinicians select targeted therapies based on a patient’s genetic profile. Improvements in testing speed and analytical accuracy are further strengthening the clinical value of genomic diagnostics. As awareness of genetic testing grows, healthcare providers are expected to increase the use of genomics in routine diagnostic practices.
Advancements in High-Throughput Sequencing Technologies
Rapid progress in sequencing technologies is significantly influencing the development of the genomics market. High-throughput sequencing platforms have improved the speed, accuracy, and cost-efficiency of genomic analysis, making large-scale genetic studies more feasible. These advancements are supporting applications in disease research, drug discovery, and clinical diagnostics. Research organizations and biotechnology companies are increasingly adopting next-generation sequencing tools to analyze complex genetic data. In addition, continuous improvements in sequencing chemistry and bioinformatics software are enhancing data interpretation capabilities. As genomic data generation becomes more efficient, sequencing technologies are expected to remain a key driver of market expansion.
Market Segmentation
- Based on the product the market is segmented into products and services.
- Based on the technology the market is segmented into sequencing, PCR, nucleic acid extraction & purification, microarray, CRISPR and other.
- Based on the application the market is segmented into drug discovery & development, diagnostics, agriculture & animal research, precision medicine and other.
- Based on the end-user the market is segmented into hospitals & clinics, academic & research institutions, pharmaceutical & biotechnology companies, clinical, research organizations (cros) and other.
Rising Demand for Genomics in Drug Discovery and Development
Drug discovery and development has emerged as one of the most significant application areas for genomics technologies as pharmaceutical companies increasingly rely on genetic insights to identify therapeutic targets. Genomic analysis enables researchers to understand disease mechanisms, detect genetic mutations, and develop targeted therapies tailored to specific patient populations. This approach has accelerated the development of precision medicines and improved the efficiency of clinical research programs. Leading organizations such as QIAGEN N.V., Agilent Technologies Inc., and Danaher Corp. are actively supporting pharmaceutical research through genomic instruments, reagents, and analytical tools. The increasing prevalence of genetic disorders and the growing emphasis on personalized healthcare solutions are further contributing to the expansion of genomics-driven drug discovery initiatives globally.
Pharmaceutical and Biotechnology Companies Drive Genomics Adoption
Pharmaceutical and biotechnology companies represent the largest end-user group in the genomics market due to their extensive use of genomic technologies in drug research and development. Genomics tools allow researchers to study disease-related genes, identify therapeutic targets, and develop personalized treatment strategies. The growing focus on targeted therapies and precision medicine has encouraged these companies to incorporate genomic analysis into early-stage research and clinical development programs. Industry leaders such as QIAGEN N.V., Agilent Technologies Inc., and Danaher Corp. supply genomic instruments, reagents, and analytical technologies that support pharmaceutical research activities. Recent developments include increased collaboration between genomics technology providers and drug developers to accelerate therapeutic discovery. As pharmaceutical innovation continues to advance, genomics is expected to remain a critical tool within modern drug development pipelines.
Regional Outlook
The global genomics market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Maintains Leadership in Genomics Innovation
North America continues to demonstrate strong momentum in genomic research and clinical applications due to its advanced biotechnology infrastructure and significant public and private research funding. The region hosts a large number of genomic research centers and clinical trials that focus on disease genomics, precision medicine, and therapeutic development. Leading companies such as Illumina, Inc., Thermo Fisher Scientific Inc., and Agilent Technologies Inc. maintain extensive research and development operations across the United States and Canada. Increasing adoption of sequencing technologies in cancer diagnostics and rare disease studies is further expanding regional demand. Government initiatives and national genome programs have also accelerated large-scale genomic data generation and clinical integration. These factors continue to strengthen North America’s position as a major hub for genomic technology development.
Asia-Pacific Emerges as a Rapidly Expanding Genomics Market
The Asia-Pacific region is gaining considerable attention in the genomics industry due to expanding biotechnology capabilities and increasing government support for genomic research initiatives. Countries such as China, Japan, and India are investing heavily in sequencing infrastructure, population genomics programs, and biotechnology innovation. Regional research institutes and pharmaceutical companies are increasingly adopting genomic technologies to support drug discovery, agricultural biotechnology, and disease diagnostics. Industry participants including BGI Genomics Co. Ltd., Oxford Nanopore Technologies Ltd., and QIAGEN N.V. are expanding collaborations and distribution networks across the region. Rising healthcare expenditure and increasing awareness of precision medicine are also contributing to stronger adoption of genomics tools. With growing research activity and government-backed genomic initiatives, Asia-Pacific is expected to remain one of the fastest-developing regions for genomics technologies.
Market Players Outlook
The major companies operating in the global genomics market include Agilent Technologies Inc, F. Hoffmann-La Roche Ltd., Illumina, Inc., Thermo Fisher Scientific Inc., and Qiagen N.V., among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In March 2026, Natera, Inc. announced the commercial launch of Zenith Genomics, a whole genome sequencing–based assay designed to improve the diagnosis of rare genetic diseases. The test incorporates advanced sequencing and long-read confirmation technologies to enhance detection of complex genomic variations and support comprehensive clinical analysis. The platform was developed in collaboration with MyOme and will be offered to healthcare providers across the US.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global genomics market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Genomics Market Sales Analysis – Deliverable | Technology | Application | End-User | ($ Million)
- Genomics Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Genomics Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Genomics Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Genomics Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Genomics Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Genomics Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Genomics Market Revenue and Share by Manufacturers
- Genomics Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Agilent Technologies Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Hoffmann-La Roche Ltd.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Illumina, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Thermo Fisher Scientific Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Qiagen N.V.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Agilent Technologies Inc.
- Key Company Analysis
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Global Genomics Market Sales Analysis by Deliverable ($ Million)
- Products
- Services
- Global Genomics Market Sales Analysis by Technology ($ Million)
- Sequencing
- PCR
- Nucleic Acid Extraction & Purification
- Microarray
- CRISPR
- Other
- Global Genomics Market Sales Analysis by Application ($ Million)
- Drug Discovery & Development
- Diagnostics
- Agriculture & Animal Research
- Precision Medicine
- Other
- Global Genomics Market Sales Analysis by End-User ($ Million)
- Hospitals & Clinics
- Academic & Research Institutions
- Pharmaceutical & Biotechnology Companies
- Clinical Research Organizations (CROs)
- Other
- Regional Analysis
- North American Genomics Market Sales Analysis – Deliverable | Technology | Application | End-User | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Genomics Market Sales Analysis – Deliverable | Technology | Application | End-User | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Genomics Market Sales Analysis – Deliverable | Technology | Application | End-User | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Genomics Market Sales Analysis – Deliverable | Technology | Application | End-User | Country ($ Million)
- Macroeconomic Factors for Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- 10x Genomics, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Agilent Technologies Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- BGI Genomics Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bio-Rad Laboratories Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Biosearch Technologies, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Clear Labs, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Danaher Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eurofins Scientific SE
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hoffmann-La Roche Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Helix OpCo LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Illumina, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Integrated DNA Technologies, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck KGaA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Pacific Biosciences of California, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- PerkinElmer Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Promega Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- QIAGEN N.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Standard BioTools Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Takara Bio Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- 10x Genomics, Inc.
1. Global Genomics Market Research and Analysis by Deliverable, 2025–2035 ($ Million)
2. Global Genomics Products Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Genomics Services Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Genomics Market Research and Analysis by Technology, 2025–2035 ($ Million)
5. Global Genomics Sequencing Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Genomics PCR Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Genomics Nucleic Acid Extraction & Purification Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Genomics Microarray Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Genomics CRISPR Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Other Genomics Technology Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Global Genomics Market Research and Analysis by Application, 2025–2035 ($ Million)
12. Global Genomics For Drug Discovery & Development Market Research and Analysis by Region, 2025–2035 ($ Million)
13. Global Genomics For Diagnostics Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Global Genomics For Agriculture & Animal Market Research Market Research and Analysis by Region, 2025–2035 ($ Million)
15. Global Genomics For Precision Medicine Market Research and Analysis by Region, 2025–2035 ($ Million)
16. Global Genomics For Other Application Market Research and Analysis by Region, 2025–2035 ($ Million)
17. Global Genomics Market Research and Analysis by End User, 2025–2035 ($ Million)
18. Global Genomics For Hospitals & Clinics Market Research and Analysis by Region, 2025–2035 ($ Million)
19. Global Genomics For Academic & Research Institutions Market Research and Analysis by Region, 2025–2035 ($ Million)
20. Global Genomics For Pharmaceutical & Biotechnology Companies Market Research Market Research and Analysis by Region, 2025–2035 ($ Million)
21. Global Genomics For Clinical Research Organizations (CROs) Market Research and Analysis by Region, 2025–2035 ($ Million)
22. Global Genomics For Other End User Market Research and Analysis by Region, 2025–2035 ($ Million)
23. Global Genomics Market Research and Analysis by Region, 2025–2035 ($ Million)
24. North American Genomics Market Research and Analysis by Country, 2025–2035 ($ Million)
25. North American Genomics Market Research and Analysis by Deliverable, 2025–2035 ($ Million)
26. North American Genomics Market Research and Analysis by Technology, 2025–2035 ($ Million)
27. North American Genomics Market Research and Analysis by Application, 2025–2035 ($ Million)
28. North American Genomics Market Research and Analysis by End-User, 2025–2035 ($ Million)
29. European Genomics Market Research and Analysis by Country, 2025–2035 ($ Million)
30. European Genomics Market Research and Analysis by Deliverable, 2025–2035 ($ Million)
31. European Genomics Market Research and Analysis by Technology, 2025–2035 ($ Million)
32. European Genomics Market Research and Analysis by Application, 2025–2035 ($ Million)
33. European Genomics Market Research and Analysis by End-User, 2025–2035 ($ Million)
34. Asia-Pacific Genomics Market Research and Analysis by Country, 2025–2035 ($ Million)
35. Asia-Pacific Genomics Market Research and Analysis by Deliverable, 2025–2035 ($ Million)
36. Asia-Pacific Genomics Market Research and Analysis by Technology, 2025–2035 ($ Million)
37. Asia-Pacific Genomics Market Research and Analysis by Application, 2025–2035 ($ Million)
38. Asia-Pacific Genomics Market Research and Analysis by End-User, 2025–2035 ($ Million)
39. Rest of the World Genomics Market Research and Analysis by Region, 2025–2035 ($ Million)
40. Rest of the World Genomics Market Research and Analysis by Deliverable, 2025–2035 ($ Million)
41. Rest of the World Genomics Market Research and Analysis by Technology, 2025–2035 ($ Million)
42. Rest of the World Genomics Market Research and Analysis by Application, 2025–2035 ($ Million)
43. Rest of the World Genomics Market Research and Analysis by End-User, 2025–2035 ($ Million)
1. Global Genomics Market Share by Deliverable, 2025 Vs 2035 (%)
2. Global Genomics Products Market Share by Region, 2025 Vs 2035 (%)
3. Global Genomics Services Market Share by Region, 2025 Vs 2035 (%)
4. Global Genomics Market Share by Technology, 2025 Vs 2035 (%)
5. Global Genomics Sequencing Market Share by Region, 2025 Vs 2035 (%)
6. Global Genomics PCR Market Share by Region, 2025 Vs 2035 (%)
7. Global Genomics Nucleic Acid Extraction & Purification Market Share by Region, 2025 Vs 2035 (%)
8. Global Genomics Microarray Market Share by Region, 2025 Vs 2035 (%)
9. Global Genomics CRISPR Market Share by Region, 2025 Vs 2035 (%)
10. Global Other Genomics Technology Market Share by Region, 2025 Vs 2035 (%)
11. Global Genomics Market Share by Application, 2025 Vs 2035 (%)
12. Global Genomics For Drug Discovery & Development Market Share by Region, 2025 Vs 2035 (%)
13. Global Genomics For Diagnostics Market Share by Region, 2025 Vs 2035 (%)
14. Global Genomics For Agriculture & Animal ResearchMarket Share by Region, 2025 Vs 2035 (%)
15. Global Genomics For Precision Medicine Market Share by Region, 2025 Vs 2035 (%)
16. Global Genomics For Other Application Market Share by Region, 2025 Vs 2035 (%)
17. Global Genomics Market Share by End-User, 2025 Vs 2035 (%)
18. Global Genomics For Hospitals & Clinics Market Share by Region, 2025 Vs 2035 (%)
19. Global Genomics For Academic & Research Institutions Market Share by Region, 2025 Vs 2035 (%)
20. Global Genomics For Pharmaceutical & Biotechnology Companies Market Share by Region, 2025 Vs 2035 (%)
21. Global Genomics For Clinical Research Organizations (CROs) Market Share by Region, 2025 Vs 2035 (%)
22. Global Genomics For Other End-User Market Share by Region, 2025 Vs 2035 (%)
23. Global Genomics Market Research and Analysis by Region, 2025–2035 ($ Million)
24. US Genomics Market Size, 2025–2035 ($ Million)
25. Canada Genomics Market Size, 2025–2035 ($ Million)
26. UK Genomics Market Size, 2025–2035 ($ Million)
27. France Genomics Market Size, 2025–2035 ($ Million)
28. Germany Genomics Market Size, 2025–2035 ($ Million)
29. Italy Genomics Market Size, 2025–2035 ($ Million)
30. Spain Genomics Market Size, 2025–2035 ($ Million)
31. Russia Genomics Market Size, 2025–2035 ($ Million)
32. Rest of Europe Genomics Market Size, 2025–2035 ($ Million)
33. India Genomics Market Size, 2025–2035 ($ Million)
34. China Genomics Market Size, 2025–2035 ($ Million)
35. Japan Genomics Market Size, 2025–2035 ($ Million)
36. South Korea Genomics Market Size, 2025–2035 ($ Million)
37. Australia and New Zealand Genomics Market Size, 2025–2035 ($ Million)
38. ASEAN Economies Genomics Market Size, 2025–2035 ($ Million)
39. Rest of Asia-Pacific Genomics Market Size, 2025–2035 ($ Million)
40. Latin America Genomics Market Size, 2025–2035 ($ Million)
41. Middle East and Africa Genomics Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
